NCT03413319View on ClinicalTrials.gov

Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 17, 2018

Primary Completion Date

November 20, 2019

Study Completion Date

November 20, 2019

Conditions
Progressive Supranuclear Palsy (PSP)
Interventions
DRUG

ABBV-8E12

Solution for infusion

Trial Locations (2)

75218

Texas Health Physicians Group /ID# 170112, Dallas

92093

University of California, San /ID# 170113, La Jolla

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY